πŸ‡ΊπŸ‡Έ FDA
Patent

US 10849970

Antibody evolution immunogens

granted A61KA61K2039/57A61K39/12

Quick answer

US patent 10849970 (Antibody evolution immunogens) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/57, A61K39/12, A61K39/21, A61P